Boothbay Fund Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Boothbay Fund Management’s Portfolio AGTC Stock Details AGTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-38,953	Closed	-$42K	–	2864
2022 Q1	$42K	Hold	38,953	–	–	﹤0.01%	2192
2021 Q4	$74K	Hold	38,953	–	–	﹤0.01%	1749
2021 Q3	$117K	Sell	38,953 -33,859	-47%	-$121K	﹤0.01%	1770
2021 Q2	$285K	Sell	72,812 -11,631	-14%	-$48.2K	0.01%	1314
2021 Q1	$428K	Sell	84,443 -143	-0.2%	-$742	0.02%	1016
2020 Q4	$346K	Hold	84,586	–	–	0.01%	895
2020 Q3	$411K	Hold	84,586	–	–	0.02%	715
2020 Q2	$469K	Hold	84,586	–	–	0.03%	597
2020 Q1	$277K	Buy	84,586 +44,032	+109%	+$232K	0.02%	587
2019 Q4	$183K	Hold	40,554	–	–	0.02%	720
2019 Q3	$169K	Sell	40,554 -4,587	-10%	-$16.6K	0.02%	663
2019 Q2	$171K	Hold	45,141	–	–	0.02%	635
2019 Q1	$189K	Buy	+45,141	New	+$158K	0.02%	613
2018 Q4	–	Sell	-58,638	Closed	-$428K	–	967
2018 Q3	$428K	Buy	58,638 +19,670	+50%	+$86.1K	0.04%	412
2018 Q2	$144K	Buy	+38,968	New	+$180K	0.01%	663
2017 Q2	–	Sell	-14,871	Closed	-$103K	–	891
2017 Q1	$103K	Buy	+14,871	New	+$116K	0.02%	671

Other funds holding AGTC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boothbay Fund Management's AGTC Position: Q2 2022 in Review

Boothbay Fund Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2022, closing a stake of 38,953 shares — an estimated $42K sold.

Boothbay Fund Management first reported a position in AGTC in Q1 2017 and held it in 16 quarters. The position peaked at $469K in Q2 2020. 47 funds tracked by Wall St. Rank hold AGTC as of Q2 2022.

Boothbay Fund Management reported no remaining Applied Genetic Technologies Corporation position as of Q2 2022 after selling out during the quarter.
Boothbay Fund Management sold 38,953 Applied Genetic Technologies Corporation shares in Q2 2022, an estimated $42K.
Boothbay Fund Management first reported a position in Applied Genetic Technologies Corporation in Q1 2017 and held it in 16 quarters.
Boothbay Fund Management's Applied Genetic Technologies Corporation position peaked at $469K in Q2 2020.
47 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2022.

Based on Boothbay Fund Management's 13F filing for Q2 2022, filed 15 Aug 2022.